Researchers eye potential Down syndrome fix via advanced gene editing

By Nancy Lapid April 17 (Reuters) - Researchers have developed a modified version of the CRISPR gene-editing tool that in ...
C&EN

Policy Watch: FDA issues draft guidance on genome-editing safety

The US Food and Drug Administration released a draft guidance document on Tuesday with recommendations for using ...
Regulatory Affairs Professionals Society

FDA drafts guidance on using next-generation sequencing to assess gene therapy safety

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...

FDA shares guide on genome editing best practices

This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating ...
Morning Overview on MSN

Compact CRISPR tool boosts in-body gene editing to 90% in lab tests

For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...
KSL

Studies test whether gene-editing can fix high cholesterol. For now, take your medicine

WASHINGTON — Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol. It's very early stage research, tried in ...
The Scientist

Gene Editing Turns the Immune System into a Custom Protein Factory

Researchers used CRISPR to edit hematopoietic stem cells, creating B cells that produce neutralizing antibodies against HIV, ...
GEN - Genetic Engineering and Biotechnology News

Engineered Miniature CRISPR Boosts Gene‑Editing Efficiency in Human Cells

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
The Best BBQ in St. Louis

Gene editing tools add new IP and regulatory considerations as they revolutionize plant science

Gene editing tools are powering new innovation in the plant sciences world, but that brings new considerations of intellectual property and regulatory risks. Ever since powerful new gene editing tools ...